Picture of Sage Therapeutics logo

SAGE — Sage Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

Biogen and Sage's neurological disorder drug fails in mid-stage trial

July 24 (Reuters) - Biogen  BIIB.O  and Sage
Therapeutics'  SAGE.O  neurological disorder drug failed in a
mid-stage trial, the companies said on Wednesday.

 (Reporting by Sriparna Roy in Bengaluru; Editing by Shilpi
Majumdar)
 ((Sriparna.Roy@thomsonreuters.com;))

Recent news on Sage Therapeutics

See all news